Monthly Archives - November 2017

Myomo Expands MyoPro® Centers of Excellence Program

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced the addition of six new orthotics and prosthetics (O&P) locations to its Center of Excellence (CoE) program, which recognizes top O&P practices that support the MyoPro line of powered orthoses. MyoPro is currently the only lightweight wearable device that can help restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, brachial plexus injury (BPI) […]

Myomo, Inc. to Present at the 10th Annual LD Micro Main Event

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5th at 9:30 AM PST / 12:30 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Chairman and Chief Executive Officer Paul R. Gudonis will be presenting, as well as meeting with investors. Read more >>

Corbus Pharmaceuticals Expands Intellectual Property Portfolio with Patent Issuance Covering the Use of Anabasum for the Treatment of Rare Fibrotic Diseases

Corbus Pharmaceuticals Holdings, Inc., a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that the U.S. Patent and Trademark Office (“USPTO”) issued U.S. Patent No. 9,820,964 to the Company with claims covering the use of pharmaceutical compositions comprising anabasum for the treatment of multiple fibrotic diseases, including the Company’s lead indications: systemic sclerosis, dermatomyositis, cystic fibrosis as well as others. Read more >>

Middleton Samaritan hopes to see again

After stopping to help someone on the freeway, and getting hit himself, Jamie Harrell spent about two months in the hospital. He is recovering now but hopes to see again after the accident left him legally blind.
Jamie and Nena are now trying to raise funds to be able to buy eSight glasses which will help him see again. Read more >>

A Wearable Tech Miracle For the Legally Blind

For Conrad Lewis, the founder of eSight, the project is close to the heart. Lewis grew up with two legally blind sisters. He studied engineering and was determined to utilize his knowledge to create glasses that could improve his sisters’ vision. After years of research, multiple patented innovations, tens of millions of dollars, and clinical tests on legally blind people, Lewis’ miracle glasses are now available to everyone. Read more >>

Price, Performance and Scale: Defining the New Possible

A big part of cloud computing is the basic issue of storage. Any data-driven business needs to store data, and these days, the amount of data is much greater than ever before. This is true for just about any industry: healthcare, media, financial services, energy, and of course the ever-important market of software-as-a-service. In any of these verticals, the cost of data storage presents a serious constraint.
That’s why David Friend and Jeff Flowers teamed up again recently to form […]

Investing. It’s a numbers game.

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies.
In episode three, Moukheiber and Powsner interview Mic Williams, founder of Boston Harbor Angels and angel investor extraordinaire, on his winning philosophy of investing — and a few stories, too. Tune in >>

A Vision of Gratitude

Though sometimes called electronic glasses, the eSight 3 isn’t a pair of spectacles but actually an augmented-reality headset, resembling a less-bulky version of a virtual-reality headset. Read more >>

NASA to Highlight Science on Next Resupply Mission to Space Station

NASA will host a media teleconference at 1 p.m. EST Wednesday, Nov. 29, to discuss a number of science investigations and instruments launching to the International Space Station on the next SpaceX commercial resupply mission. Brian Hess, chief executive officer, and Grayson Allen, chief financial officer, both of LaunchPad Medical, will discuss an investigation using synthetic bone material to accelerate bone repair. Read more >>